7 completed. 2 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Afluria: new trials by email Literature Review of Afluria trials Research Report on Afluria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Afluria Pregnancy Registry Afluria Influenza Vaccine - Influenza, Human, Pregnancy | Completed | Seqirus | 490 | 2017-09-08 | 2022-02-09 | |
| Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab Pneumococcal Pneumonia vaccine, Influenza vaccine, Hepatitis B vaccine - Inflammatory Bowel Diseases | Completed | Boston Medical Center | 173 | 2017-07-05 | 2019-12-30 | |
| Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age Flublok, Afluria - Influenza | Phase 3 | Completed | Protein Sciences Corporation | 2640 | 2013-03-01 | 2015-02-18 |
| FluMist in Egg Allergic Patients FluMist intranasal influenza vaccine, Intramuscular influenza injection ("flu shot") - Egg Allergy, Eligible for Vaccination Against Influenza | Phase 1 / Phase 2 | Completed | Walter Reed Army Medical Center | 17 | 2010-09-01 | 2018-10-03 |
| A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population CSL's Influenza Virus Vaccine (Afluria), Influenza Virus Vaccine (Fluzone) - Influenza | Phase 3 | Completed | Seqirus | 1474 | 2009-09-01 | 2017-05-16 |
| Immune Responses Induced by Different Licensed Influenza Vaccines Flulaval, Fluvirin, Fluzone - Immune Response | Not applicable | Completed | University of Massachusetts, Worcester | 193 | 2008-10-01 | 2017-11-20 |
| A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine (Fluzone®) - Influenza | Phase 4 | Completed | Seqirus | 1268 | 2008-10-01 | 2018-05-23 |
Influenza, Human (6) · Congenital Abnormalities (1) · Egg Hypersensitivity (1) · Inflammatory Bowel Diseases (1)
Seqirus (3) · Boston Medical Center (1) · Protein Sciences Corporation (1) · University of Massachusetts, Worcester (1) · Walter Reed Army Medical Center (1)
United States (7)
Alan C. Wine, MD (1) · Bob Weiss, MD (1) · Brandon Essink, MD (1) · Darrell Herrington, DO (1) · Eric Sheldon (1) · Frank Eder, MD (1) · George Bauer, MD (1) · Jeffrey Rosen, MD (1) · Joe Blumenau, MD (1) · Leah Schmidt, DO (1) · Mary Dawn T Co, MD (1) · Paul Bradley, MD (1) · Sharmeel K Wasan, MD (1)